Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules
Conditions: Healthy Volunteers; Bioequivalence Study Interventions: Drug: Neurogabin (Gabapentin) 400 mg capsule; Drug: Parketin (Gabapentin) 400 mg capsule Sponsors: University of Karachi; Merck Pvt. Ltd, Pakistan; Center for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research Institute of chemistry, University of Karachi Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Chemistry | Gabapentin | Neurology | Neurontin | Pakistan Health | Research | Study